April 27, 2006
American Medical Systems Holdings, Inc. acquires assets and an exclusive license for the use of technology in urology, gynecology and other pelvic health applications from Willkie client BioControl Medical, Ltd.
On April 26, American Medical Systems Holdings, Inc. acquired assets and an exclusive license for the use of technology in urology, gynecology and other pelvic health applications from Willkie client BioControl Medical, Ltd. The transaction involved initial payments and milestones totaling $50 million as well as royalty payments. BioControl is an Israeli company focused on the development of medical devices for the application of implantable electrical stimulation technology. The acquisition of the BioControl technology will allow AMS to finalize development of its miniaturo™ system for the treatment of urge incontinence and interstitial cystitis, which affects nearly 60 million people globally. The transaction was handled by partner Peter Jakes.